| dc.contributor.author | Rao, Gayatri M. | |
| dc.contributor.author | Mudaraddi, Rakesh | |
| dc.contributor.author | Hadapad, Ramesh | |
| dc.contributor.author | Sameer | |
| dc.contributor.author | Sreekantha | |
| dc.date.accessioned | 2012-11-26T05:59:35Z | |
| dc.date.available | 2012-11-26T05:59:35Z | |
| dc.date.issued | 2011-01 | |
| dc.identifier.citation | International Journal of Pharma and Bio Sciences. 2011 Jan-Mar; 2(1): 256-261. | en_US |
| dc.identifier.issn | 0975-6299 | |
| dc.identifier.uri | http://hdl.handle.net/123456789/211 | |
| dc.description.abstract | Advanced oxidation protein product (AOPP) and protein carbonyl (PC) as protein oxidation products (PPP) and antioxidants such as reduced glutathione (GSH),total thiol (TT) and albumin levels were analyzed in 27 patients with diagnosed primary brain tumor and 25 normal healthy age and sex matched controls. Statistically significant increased (p-0.001) levels of AOPP and PC were noted; GSH and TT levels were increased (p-0.833) & (p-0.032) respectively with decreased albumin levels (p-0.629).Hence increased oxidative stress signified by increased PPP and altered antioxidant levels may have a role in etipathogenesis of primary brain tumor. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | P. Muthuprasanna | en_US |
| dc.subject | Brain neoplasms | en_US |
| dc.subject | Advanced oxidation protein products | en_US |
| dc.subject | Antioxidants | en_US |
| dc.subject | Reduced glutathione | |
| dc.title | Study of protein oxidation products and antioxidants status in primary brain tumor patients | en_US |
| dc.type | Article | en_US |